scholarly journals A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

2016 ◽  
Vol 42 (9) ◽  
pp. 1914-1923 ◽  
Author(s):  
Daniel Umbricht ◽  
Marta del Valle Rubido ◽  
Eric Hollander ◽  
James T McCracken ◽  
Frederick Shic ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Single Dose ◽  
Receptor Antagonist ◽  
Autism Spectrum ◽  
Mechanism Study ◽  
Adults With Autism ◽  
High Functioning ◽  
Randomized Controlled ◽  
Vasopressin 1A Receptor ◽  
Proof Of Mechanism

Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder

2020 ◽  
Vol 63 (4) ◽  
pp. 1511-1525 ◽  
Author(s):  
Patrick Schnider ◽  
Caterina Bissantz ◽  
Andreas Bruns ◽  
Cosimo Dolente ◽  
Erwin Goetschi ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Receptor Antagonist ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Vasopressin 1A Receptor
Sign in / Sign up

Export Citation Format

Share Document